An overview of some potential immunotherapeutic options against COVID-19

After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despite relentless efforts to control the disease by drug repurposing, there is...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int Immunopharmacol
Hoofdauteurs: Bayat, Maryam, Asemani, Yahya, Mohammadi, Mohammad Reza, Sanaei, Mahsa, Namvarpour, Mozhdeh, Eftekhari, Reyhaneh
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier B.V. 2021
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908848/
https://ncbi.nlm.nih.gov/pubmed/33765610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107516
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items